Skip to main content
Shilpa Kodati, MD, Ophthalmology, Bethesda, MD, University of Michigan Medical Center

ShilpaKodatiMD

Ophthalmology Bethesda, MD

Retinal Disease, Uveitis

Vitreoretinal Surgeon and Uveitis specialist

Dr. Kodati is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kodati's full profile

Already have an account?

Summary

  • Dr. Shilpa Kodati is an ophthalmologist in Bethesda, MD. She specializes in vitreoretinal surgery and uveitis and is experienced in uveitis, retina surgery, immunology, vitreoretinal disease, and retinal imaging.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Surgical Retina and Vitreous, 2017 - 2019
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Ocular Immunology/Uveitis, 2016 - 2017
  • UPMC Medical Education
    UPMC Medical EducationResidency, Ophthalmology, 2013 - 2016
  • MetroWest Medical Center
    MetroWest Medical CenterInternship, Transitional Year, 2012 - 2013
  • Imperial College London School of Medicine
    Imperial College London School of MedicineClass of 2008

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2022 - 2025
  • DC State Medical License
    DC State Medical License 2020 - 2024
  • TX State Medical License
    TX State Medical License 2017 - 2024
  • PA State Medical License
    PA State Medical License 2013 - 2024
  • American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • First U.S. Patient Receives Autologous Stem Cell Therapy to Treat Dry AMD
    First U.S. Patient Receives Autologous Stem Cell Therapy to Treat Dry AMDSeptember 2nd, 2022
  • First US Patient Gets Autologous Stem Cell Therapy to Treat Dry AMD
    First US Patient Gets Autologous Stem Cell Therapy to Treat Dry AMDSeptember 1st, 2022
  • ARVO Foundation Announces 2021 Mallinckrodt Uveitis Research Fellowship Recipient
    ARVO Foundation Announces 2021 Mallinckrodt Uveitis Research Fellowship RecipientJanuary 21st, 2021

Professional Memberships

Hospital Affiliations